![Bob Cunard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Cunard
Private Equity Investor chez
HealthEdge Investment Partners, LLC
Profil
Bob Cunard currently works at HealthEdge Investment Partners, LLC, as Operating Partner from 2017.
Mr. Cunard also formerly worked at Aurobindo Pharma USA, Inc., as Chief Executive Officer from 2011 to 2017, Columbus Organization Holdings LLC, as Chief Executive Officer & Director from 2017 to 2020, Granules India Ltd., as Independent Non-Executive Director from 2019 to 2023, Mylan Laboratories, Inc., as SVP, Marketing & Strategic Development from 1999 to 2006, Teva Pharmaceutical Industries Ltd., as VP & Sales from 2009 to 2011, and Stiefel Laboratories, Inc., as SVP Lifecycle Management from 2008 to 2009.
Mr. Cunard received his undergraduate degree in 1990 from the University of Pittsburgh.
Postes actifs de Bob Cunard
| Sociétés | Poste | Début |
|---|---|---|
HealthEdge Investment Partners, LLC
 HealthEdge Investment Partners, LLC Investment ManagersFinance HealthEdge Investment Partners invests in both public and private lower middle market companies located in the United States with an EBITDA of USD 2 - 15 million and revenues of USD 5 - 75 million. The firm target companies operating in the field of the healthcare sector. It provides financing for buyouts, recapitalizations and growth capital requirements. It also makes majority and significant minority control investments in companies. | Private Equity Investor | 01/06/2017 |
Anciens postes connus de Bob Cunard
| Sociétés | Poste | Fin |
|---|---|---|
| GRANULES INDIA LIMITED | Directeur/Membre du Conseil | 17/03/2023 |
Columbus Organization Holdings LLC
 Columbus Organization Holdings LLC Medical/Nursing ServicesHealth Services Functions as an holding company with interest provides care co-ordination and clinical staffing services | Directeur Général | 02/01/2020 |
Aurobindo Pharma USA, Inc.
 Aurobindo Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and active pharmaceutical ingredients | Directeur Général | 30/06/2017 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 31/10/2011 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | 01/05/2009 |
Formation de Bob Cunard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Granules India Ltd.
 Granules India Ltd. Pharmaceuticals: OtherHealth Technology Engages in manufacturing and marketing of pharmaceuticals | Health Technology |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aurobindo Pharma USA, Inc.
Aurobindo Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceuticals and active pharmaceutical ingredients | Health Technology |
HealthEdge Investment Partners, LLC
HealthEdge Investment Partners, LLC Investment ManagersFinance HealthEdge Investment Partners invests in both public and private lower middle market companies located in the United States with an EBITDA of USD 2 - 15 million and revenues of USD 5 - 75 million. The firm target companies operating in the field of the healthcare sector. It provides financing for buyouts, recapitalizations and growth capital requirements. It also makes majority and significant minority control investments in companies. | Finance |
Columbus Organization Holdings LLC
Columbus Organization Holdings LLC Medical/Nursing ServicesHealth Services Functions as an holding company with interest provides care co-ordination and clinical staffing services | Health Services |
